SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-065899
Filing Date
2024-05-29
Accepted
2024-05-29 16:03:07
Documents
13
Period of Report
2024-05-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-20240522.htm   iXBRL 8-K 81785
2 EX-10.1 life-ex10_1.htm EX-10.1 132429
3 EX-14.1 life-ex14_1.htm EX-14.1 86911
  Complete submission text file 0000950170-24-065899.txt   465937

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT life-20240522.xsd EX-101.SCH 27203
16 EXTRACTED XBRL INSTANCE DOCUMENT life-20240522_htm.xml XML 4710
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 24998252
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)